Calidi Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $28,992,000.
Profit Margin
| 2020 | 0 | -7.93M | |
|---|---|---|---|
| 2023 | 0 | -29.21M |
CLDI Income Statement (2020 – 2023)
| 2023 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 0 | 0 |
Cost of revenue | 1.25M | 0 |
Gross profit | -1.25M | 0 |
Operating exp. | ||
Research and development | 13.00M | 3.18M |
Selling and marketing | 0 | 0 |
Total operating expenses | 28.99M | 6.77M |
Operating income | -28.99M | -6.77M |
Other income (expenses), net | -208K | -1.16M |
Income before tax | -29.2M | -7.93M |
Income tax expense | 16K | 4K |
Net income | -29.21M | -7.93M |
Earnings per share | ||
Basic EPS | -1.73 | -0.22 |
Diluted EPS | -17.3 | -0.22 |